Fennec Pharmaceuticals

FENC

Börsenwert 344 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Southpoint Capital Advisors New York	33,8 Mio. $	–	–	–
2	2 Solas Capital Management Darien, Connecticut	18,5 Mio. $	-123.247 $	-18.017	-0,8 %
3	3 Rosalind Advisors Toronto, Ontario, Canada	17 Mio. $	+1,8 Mio. $	+262.800	+15 %
4	4 BlackRock New York	10,2 Mio. $	-163.155 $	-23.851	-2 %
5	5 Vanguard Group Malvern, Pennsylvania	8,03 Mio. $	+16.910 $	+2.472	+0,3 %
6	ACM 6 AIGH Capital Management Baltimore, Maryland	3,75 Mio. $	+625.197 $	+91.395	+25 %
7	7 State Street Boston, Massachusetts	2,79 Mio. $	-11.212 $	-1.639	-0,5 %
8	8 Geode Capital Management Boston, Massachusetts	2,53 Mio. $	-46.071 $	-6.735	-2 %
9	9 Harbert Fund Advisors Birmingham, Alabama	2,39 Mio. $	-1,23 Mio. $	-179.255	-38 %
10	10 Morgan Stanley New York	2,11 Mio. $	-290.007 $	-42.395	-14 %
11	LPC 11 Lion Point Capital New York	1,62 Mio. $	–	–	–
12	GJL 12 Gendell Jeffrey L	1,16 Mio. $	-379.756 $	-55.515	-28 %
13	13 Northern Trust Chicago, Illinois	1,09 Mio. $	-47.221 $	-6.903	-5 %
14	14 EAM Investors Solana Beach, California	652.886 $	+538.088 $	+78.661	Neu
15	15 Charles Schwab San Francisco, California	508.682 $	+965 $	+141	+0,2 %
16	16 Bank of New York Mellon New York	430.043 $	-11.588 $	-1.694	-3 %
17	17 Hartford Financial Management Hartford, Connecticut	420.362 $	+5.459 $	+798	+2 %
18	18 Jane Street New York	414.909 $	+241.275 $	+35.271	+240 %
19	19 Susquehanna International Group Bala Cynwyd, Pennsylvania	388.863 $	+113.506 $	+16.593	+55 %
20	20 Citadel Advisors Miami, Florida	388.299 $	+320.024 $	+46.783	Neu
21	21 Barclays London, United Kingdom	332.042 $	+107.425 $	+15.704	+65 %
22	22 RhumbLine Advisers Boston, Massachusetts	281.336 $	+3.646 $	+533	+2 %
23	MHP 23 Manatuck Hill Partners Westport, Connecticut	250.660 $	+206.586 $	+30.200	Neu
24	24 Arrowstreet Capital Boston, Massachusetts	224.557 $	+185.072 $	+27.055	Neu
25	25 Nuveen Charlotte, North Carolina	215.850 $	–	–	–

Fennec Pharmaceuticals FENC Börsenwert 344 Mio. $

Fennec Pharmaceuticals

FENC

Börsenwert 344 Mio. $